Target (CBDY) Operating Expenses (2013 - 2026)
Target (CBDY) reported Operating Expenses of $501674.0 for Q1 2026, down 18.72% year-over-year from $617253.0 in Q1 2025, and down 7.78% quarter-over-quarter from $543973.0 in Q4 2025.
Target (CBDY) Operating Expenses (2013 - 2026) Analysis & Trends
Target (CBDY) has 14 years of Operating Expenses data on file, last reported at $501674.0 in Q1 2026.
- Operating Expenses for Q1 2026 came in at $501674.0, down 18.72% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.2 million (down 13.96% YoY), and the FY2025 annual result was $2.3 million, down 12.23% from the prior year.
- Operating Expenses slipped to $501674.0 in Q1 2026 per CBDY's latest filing, from $543973.0 in the prior quarter.
- Over five years, Operating Expenses peaked at $735936.0 in Q4 2024 and troughed at $146912.6 in Q4 2022.
- A 5-year average of $502712.6 and a median of $543973.0 in 2025 frame the typical range for Operating Expenses.
- The sharpest annual moves came in 2022 and 2023: Operating Expenses slumped 38.5% in 2022, then soared 306.13% in 2023.
- A 5-year view of Operating Expenses shows it stood at $146912.6 in 2022, then soared by 306.13% to $596650.0 in 2023, then grew by 23.34% to $735936.0 in 2024, then decreased by 26.08% to $543973.0 in 2025, then decreased by 7.78% to $501674.0 in 2026.
- Business Quant data shows CBDY's Operating Expenses at $501674.0 in Q1 2026, $543973.0 in Q4 2025, and $520011.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 526.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 788.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 455.70 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 19.40 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 621.10 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 478.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 441.19 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 96.91 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 475.11 Mn |
| 10 | Target | - | - | 191,787.00 | 501,674.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 501,674.00 |
| Dec 31, 2025 | 543,973.00 |
| Sep 30, 2025 | 520,011.00 |
| Jun 30, 2025 | 608,294.00 |
| Mar 31, 2025 | 617,253.00 |
| Dec 31, 2024 | 735,936.00 |
| Sep 30, 2024 | 605,888.00 |
| Jun 30, 2024 | 567,671.00 |
| Mar 31, 2024 | 699,013.00 |
| Dec 31, 2023 | 596,650.00 |
| Sep 30, 2023 | 648,489.00 |
| Jun 30, 2023 | 500,448.00 |
| Mar 31, 2023 | 340,712.00 |
| Dec 31, 2022 | 146,912.56 |
| Sep 30, 2022 | 278,507.00 |
| Jun 30, 2022 | 286,490.00 |
| Mar 31, 2022 | 348,193.00 |
| Dec 31, 2021 | 238,898.88 |
| Sep 30, 2021 | 427,414.00 |
| Jun 30, 2021 | 372,782.00 |